PROPRIETARY DELIVERY MEDIA  ·  MADE IN THE USA
PP-01 — Oromucosal Delivery Media
PERMEAPULSE™️ OROMUCOSAL DELIVERY TECHNOLOGY

Your molecule.Designed fororomucosal delivery.

  • Molecule-specific development
  • Formulation science
  • Analytical validation
  • Scale-up support
Fig. 01Oromucosal formulation media
A — ORAL CAVITY, SAGITTAL VIEWPALATEBUCCALFLOOR OF MOUTHTONGUESUBLINGUAL DOSEB — MUCOSAL MEMBRANE, DETAILMUCOADHESIVE LAYER — DOSE HELD AT SITEEPITHELIUM — PERMEATION SUPPORTCAPILLARY BEDC — SYSTEMIC CIRCULATIONDirect entry via mucosaNo gastric transit before circulationREFERENCE — ORAL / GI ROUTEStomach → liver first passWhere conventional oral routes fall short
  1. 01Sublingual administrationA fine mist is delivered beneath the tongue
  2. 02Mucosal retentionDesigned to increase the amount of time the formulation remains in contact with the mucosal surface
  3. 03Permeation supportFormulation strategies are designed to support movement across the oral epithelium
  4. 04Molecular stabilizationControlled formulation conditions can be tailored to help maintain active-ingredient integrity

Sublingual anatomy — thin mucosal tissue with a rich underlying blood supply provides an alternative pathway for oromucosal delivery.

Built for commercial development

From molecule assessment
to finished formulation.

Different molecules present different delivery challenges. PermeaPulse™ formulations can be developed around molecular characteristics, concentration, stability, pH, permeability profile, residence time, and intended administration site.

01

Molecule Assessment

Evaluate molecular characteristics, concentration, stability, permeability, and administration requirements before formulation development.

02

Formulation Development

Develop a molecule-specific environment around retention, permeability, pH, stability, and the intended administration site.

03

Scientific Characterization

Finished formulations are evaluated using appropriate analytical and pharmacokinetic studies.

04

Scale-Up

Translate the optimized formulation towards consistent finished-product production and commercial development.

Scientific validation

Performance that is
measured.

Oromucosal administration does not automatically produce systemic exposure equivalent to injection or other established delivery routes. Absorption can vary depending on the molecule, formulation, and individual physiology.

  • Absorption
  • Bioavailability
  • Time to Peak Concentration
  • Maximum Concentration
  • Overall Systemic Exposure
  • Duration of Exposure

Pharmacokinetic studies can be used to scientifically characterize the performance of individual formulations.

Why it's different

Why the same active ingredient works better under the tongue.

A swallowed pill has to survive the stomach before it can work. PermeaPulse absorbs directly through the lining of the mouth, so more of the active ingredient gets where it needs to go.

A swallowed pill
Broken down in digestion
Swallowed as a pill
→
Stomach acid and enzymes break it down
→
Little survives to the bloodstream
PermeaPulse, under the tongue
Skips the stomach
One spray under the tongue
→
Absorbs through the blood-rich lining of the mouth
→
Delivered straight to the bloodstream
The Technology

Four things happen at the surface of the mouth.

Purpose-built. Science-driven. Designed for advanced drug delivery.

PermeaPulse amber sublingual spray bottle

Designed to increase the amount of time a formulation remains in contact with the mucosal surface.

Designed to support movement of active molecules across the oral barrier.

Helps maintain the integrity of the active ingredient throughout formulation, storage, and administration.

Supports the integrity and usability of multi-dose finished products.

03 / Routes

Where the molecule enters changes everything.

PermeaPulse is built around the oral mucosa, the tissues of the mouth that offer an alternative to the digestive route.

Conventional oralCapsules, tablets, swallowed liquids travel through the stomach and gut, where acid, enzymes, and first-pass metabolism can break much of it down.
SublingualBeneath the tongue. Thin, blood-rich tissue that, for suitable molecules, can absorb relatively quickly through the oral mucosa.
BuccalAlong the inner cheek. A stable surface well-suited to formulations designed to stay in contact with the mucosa for longer.
04 / Delivery Media

Built per molecule. Measured individually.

Molecular size, structure, stability, and permeability all affect whether a molecule suits oromucosal delivery. Each formulation is developed around the molecule, then its performance is measured.

Characterized by PK study
AbsorptionMeasured
BioavailabilityMeasured
Time to peakTmax
Peak concentrationCmax
Overall exposureAUC
DurationMeasured

Oromucosal administration does not automatically match injection or other established routes, and absorption varies by molecule, formulation, and individual physiology. Finished formulations are evaluated individually.

What does "under the tongue" actually do?
The tissue beneath the tongue is thin and rich in blood vessels, so an active ingredient placed there can absorb directly into the bloodstream instead of being swallowed and broken down in the stomach.
How is this different from injecting?
Injection places the active ingredient directly into tissue or the bloodstream. PermeaPulse is administered in the mouth, where the active ingredient absorbs through the oral mucosa. Oromucosal administration does not automatically produce exposure equivalent to injection; each finished formulation is characterized individually.
Does every active ingredient work with the technology?
Unfortunately no. A molecule's size, structure, stability, and permeability all affect whether it suits oromucosal delivery.
How do you know it works?
Each finished formulation is characterized with pharmacokinetic studies measuring absorption, bioavailability, time to peak, peak concentration, exposure, and duration. Results vary by molecule.
Is it safe?
The technology delivers across the body's own mucosal tissues, and permeation enhancement is designed to be temporary and supportive rather than forceful. Products can include antimicrobial protection for multi-dose use. End-use safety and compliance rest with the brand bringing the finished product to market.
Can it be used for compounding pharmacies?
PermeaPulse is a delivery media adaptable to individual molecules. This technology was designed specifically for pharmaceutical companies, labs and pharmacies.
06 / Wholesale

Built into your product line.

This technology was designed specifically for pharmaceutical companies, labs and pharmacies. Available wholesale for use in your own product line.

BULK SUPPLY
Wholesale volumes for high-volume partners
MULTI-SKU
Apply the delivery media across your catalog
CUSTOM FORMULATION
Molecule-specific development, built for you
Not the right volume? We will point you to a partner who is.
07 / Discuss your molecule

Tell us about the active ingredient you are developing.

Our team can begin by reviewing the molecule, target concentration, intended administration route, and formulation requirements.

Designed to Deliver

A purpose-built oromucosal delivery media. Proudly U.S.-based.

For business and wholesale inquiries only. Not intended for direct-to-consumer sale. PermeaPulse™ is a delivery media technology; statements on this site have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual formulations should be evaluated on their own merits. © 2026 PermeaPulse. All rights reserved.